Synthego

Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute

by

Patent Trial and Appeal Board Invalidates Agilent U.S. Patents 10,337,001 and 10,900,034 REDWOOD CITY, Calif., May 17, 2023 /PRNewswire/ — Synthego Corp., a leading provider of genome engineering solutions, has announced a victory in its dispute with Agilent Technologies, Inc., regarding two of Agilent’s patents which have been invalidated today by a ruling of the … Read more

Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines

by

Facility Sets the Standard for Quality and Efficiency of Clinical Guide RNA Therapeutic and Diagnostic Manufacturing REDWOOD CITY, Calif., May 11, 2023 /PRNewswire/ — Synthego Corp., a leading provider of genome engineering solutions, announced today the opening of its state-of-the-art GMP synthesis facility. This new 18,000 square-foot facility supports the growing demand for development of high-quality, CRISPR-enabled … Read more